Carragelose lozenges show promising activity against respiratory viruses including SARS-CoV-2 Feb. 25, 2021
Pelareorep plus CAR T-cell therapy show synergistic activity in preclinical models of solid tumors Feb. 25, 2021
Enrollment completed in phase II study of SSS-06 long-acting erythropoietin-stimulating protein Feb. 25, 2021
Janssen opens phase III study of rilematovir in neonates, infants and children with RSV infection Feb. 25, 2021
New phase II trial evaluates BIVV-020 in chronic inflammatory demyelinating polyneuropathy Feb. 25, 2021
RSS